Temple Therapeutics BV
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.templerx.com
A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions
Phase 1
Completed
- Conditions
- Pelvic Adhesions
- Interventions
- Drug: Physiologic salineDrug: L-Alanyl/L-Glutamine
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Temple Therapeutics BV
- Target Recruit Count
- 47
- Registration Number
- NCT01701193
- Locations
- 🇺🇦
8Surgery and Endoscopy Department of Kharkiv Medical Academy of Postgraduate Education Kharkiv City Clinical Multi-field Hospital, Kharkiv, Ukraine
© Copyright 2025. All Rights Reserved by MedPath